NCT02143154View on ClinicalTrials.gov

Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis

CompletedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 3, 2018

Study Completion Date

October 3, 2018

Conditions
GBS PositiveWomen in Labor Given Vancomycin for Prophylaxis
Trial Locations (1)

02905

Women & Infants Hospital, Providence

All Listed Sponsors
lead

Women and Infants Hospital of Rhode Island

OTHER

NCT02143154 - Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis | Biotech Hunter | Biotech Hunter